Wang Y - Search Results

1

Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN.

Han M, Liu M, Wang Y, Chen X, Xu J, Sun Y, Zhao L, Qu H, Fan Y, Wu C. Han M, et al. Among authors: wang y. PLoS One. 2012;7(6):e39520. doi: 10.1371/journal.pone.0039520. Epub 2012 Jun 25. PLoS One. 2012. PMID: 22761812 Free PMC article.

2

Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells.

Han M, Liu M, Wang Y, Mo Z, Bi X, Liu Z, Fan Y, Chen X, Wu C. Han M, et al. Among authors: wang y. Mol Cell Biochem. 2012 Apr;363(1-2):427-36. doi: 10.1007/s11010-011-1195-5. Epub 2011 Dec 21. Mol Cell Biochem. 2012. PMID: 22187223

3

MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells.

Han M, Wang Y, Liu M, Bi X, Bao J, Zeng N, Zhu Z, Mo Z, Wu C, Chen X. Han M, et al. Among authors: wang y. Cancer Sci. 2012 Jun;103(6):1058-64. doi: 10.1111/j.1349-7006.2012.02281.x. Epub 2012 Apr 23. Cancer Sci. 2012. PMID: 22435731 Free PMC article.

4

MicroRNA-21 induces breast cancer cell invasion and migration by suppressing smad7 via EGF and TGF-β pathways.

Han M, Wang F, Gu Y, Pei X, Guo G, Yu C, Li L, Zhu M, Xiong Y, Wang Y. Han M, et al. Among authors: wang f, wang y. Oncol Rep. 2016 Jan;35(1):73-80. doi: 10.3892/or.2015.4360. Epub 2015 Oct 29. Oncol Rep. 2016. PMID: 26531758

5

MicroR-760 suppresses cancer stem cell subpopulation and breast cancer cell proliferation and metastasis: By down-regulating NANOG.

Han ML, Wang F, Gu YT, Pei XH, Ge X, Guo GC, Li L, Duan X, Zhu MZ, Wang YM. Han ML, et al. Biomed Pharmacother. 2016 May;80:304-310. doi: 10.1016/j.biopha.2016.03.024. Epub 2016 Apr 5. Biomed Pharmacother. 2016. PMID: 27133070

6

microRNA-30d mediated breast cancer invasion, migration, and EMT by targeting KLF11 and activating STAT3 pathway.

Han M, Wang Y, Guo G, Li L, Dou D, Ge X, Lv P, Wang F, Gu Y. Han M, et al. Among authors: wang f, wang y. J Cell Biochem. 2018 Nov;119(10):8138-8145. doi: 10.1002/jcb.26767. Epub 2018 Jun 19. J Cell Biochem. 2018. PMID: 29923255

7

lncRNA GHET1 knockdown suppresses breast cancer activity in vitro and in vivo.

Han M, Wang Y, Gu Y, Ge X, Seng J, Guo G, Zhang X, Zhao Y, Dou D. Han M, et al. Among authors: wang y. Am J Transl Res. 2019 Jan 15;11(1):31-44. eCollection 2019. Am J Transl Res. 2019. PMID: 30787968 Free PMC article.

8

Identification of differentially expressed genes and biological pathways in para-carcinoma tissues of HCC with different metastatic potentials.

Liu Y, Deng M, Wang Y, Wang H, Li C, Wu H. Liu Y, et al. Among authors: wang h, wang y. Oncol Lett. 2020 Jun;19(6):3799-3814. doi: 10.3892/ol.2020.11493. Epub 2020 Mar 29. Oncol Lett. 2020. PMID: 32382332 Free PMC article.

9

Minimally Invasive Pedicle Screw Fixation Combined with Percutaneous Kyphoplasty Under O-Arm Navigation for the Treatment of Metastatic Spinal Tumors with Posterior Wall Destruction.

Zhou ZZ, Wang YM, Liang X, Ze X, Liu H, Chen KW, Zhu XY, Sun ZY, Qian ZL. Zhou ZZ, et al. Orthop Surg. 2020 Aug;12(4):1131-1139. doi: 10.1111/os.12712. Epub 2020 Jun 23. Orthop Surg. 2020. PMID: 32578396 Free PMC article.

10

Kyphoplasty for occult and non-occult osteoporotic vertebral fractures: a retrospective study.

Zhou Z, Sun Z, Wang Y, Zhu X, Qian Z. Zhou Z, et al. Among authors: wang y. J Int Med Res. 2020 Apr;48(4):300060519894764. doi: 10.1177/0300060519894764. Epub 2019 Dec 30. J Int Med Res. 2020. PMID: 31885305 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

298,851 results

Search Page

Filters